Business Insider4h
PTC Therapeutics Gains Buy Rating Following FDA Approval of Groundbreaking Gene Therapy Kebilidi
Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...
Business Insider4h
Barclays Remains a Hold on PTC Therapeutics (PTCT)
Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...
SFGate8d
PTC Inc.: Fiscal Q4 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share.
PTC Therapeutics wins FDA nod for gene therapy
PTC Therapeutics (NASDAQ:PTCT) has received FDA approval for its gene replacement therapy Kebilidi for the treatment of ...
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
PTC Inc.: Fiscal Q4 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share. Earnings, ...